LPAR3 Antikörper (AA 101-200) (Biotin)
Kurzübersicht für LPAR3 Antikörper (AA 101-200) (Biotin) (ABIN681135)
Target
Alle LPAR3 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 101-200
-
Kreuzreaktivität
- Human, Maus
-
Homologie
- Rat,Dog,Cow,Pig,Horse,Rabbit
-
Aufreinigung
- Purified by Protein A.
-
Immunogen
- KLH conjugated synthetic peptide derived from human EDG7/LPA3
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
-
WB 1:300-5000
IHC-P 1:200-400
IHC-F 1:100-500 -
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- 1 μg/μL
-
Buffer
- Aqueous buffered solution containing 0.01M TBS ( pH 7.4) with 1 % BSA, 0.03 % Proclin300 and 50 % Glycerol.
-
Konservierungsmittel
- ProClin
-
Vorsichtsmaßnahmen
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- Store at -20°C for 12 months.
-
Haltbarkeit
- 12 months
-
-
- LPAR3 (Lysophosphatidic Acid Receptor 3 (LPAR3))
-
Andere Bezeichnung
- LPA3
-
Hintergrund
-
Synonyms: EDG7, GPCR, LPA3, Edg-7, LP-A3, HOFNH30, RP4-678I3, Lysophosphatidic acid receptor 3, LPA receptor 3, LPA-3, Lysophosphatidic acid receptor Edg-7, LPAR3
Background: Receptor for lysophosphatidic acid (LPA), a mediator of diverse cellular activities. May play a role in the development of ovarian cancer. Seems to be coupled to the G(i)/G(o) and G(q) families of heteromeric G proteins.
-
Gen-ID
- 23566
-
UniProt
- Q9UBY5
-
Pathways
- Regulation of Cell Size
Target
-